Literature DB >> 3945166

Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines.

S Albouz, F Le Saux, D Wenger, J J Hauw, N Baumann.   

Abstract

Phenothiazines and tricyclic antidepressants, when added to culture medium, gave rise in several types of cells (C6 rat glioma cells and human fibroblasts), to a decrease in lysosomal sphingomyelinase activity. The effect of chlorpromazine and desipramine was dose dependent, and was observed after 3 hours of incubation with the drugs at concentrations ranging between 1 and 10 microM. In C6 glioma cell cultures, the decrease in sphingomyelinase activity was related to the clinical effectiveness of phenothiazines, tricyclic antidepressants and derivatives. Incorporation of (choline-14C) sphingomyelin showed that the metabolic pathway implying the synthesis of phosphatidylcholine from the hydrolysis of sphingomyelin and/or transfer of phosphorylcholine to phosphatidylcholine was also partially reduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945166     DOI: 10.1016/0024-3205(86)90083-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.

Authors:  Cosima Rhein; Stefan Löber; Peter Gmeiner; Erich Gulbins; Philipp Tripal; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2018-09-06       Impact factor: 3.575

2.  Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity.

Authors:  M R Hutchinson; L C Loram; Y Zhang; M Shridhar; N Rezvani; D Berkelhammer; S Phipps; P S Foster; K Landgraf; J J Falke; K C Rice; S F Maier; H Yin; L R Watkins
Journal:  Neuroscience       Date:  2010-04-08       Impact factor: 3.590

3.  Protein kinase C-δ isoform mediates lysosome labilization in DNA damage-induced apoptosis.

Authors:  Nicolas Parent; Max Scherer; Gerhard Liebisch; Gerd Schmitz; Richard Bertrand
Journal:  Int J Oncol       Date:  2010-12-20       Impact factor: 5.650

4.  High activity of acid sphingomyelinase in major depression.

Authors:  J Kornhuber; A Medlin; S Bleich; V Jendrossek; A W Henkel; J Wiltfang; E Gulbins
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

Review 5.  Acid sphingomyelinase in macrophage biology.

Authors:  Jean-Philip Truman; Mohammed M Al Gadban; Kent J Smith; Samar M Hammad
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

Review 6.  Non-pharmacological factors that determine drug use and addiction.

Authors:  Serge H Ahmed; Aldo Badiani; Klaus A Miczek; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2018-09-01       Impact factor: 8.989

7.  Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy.

Authors:  Joseph A Caruso; Patricia A Mathieu; John J Reiners
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

8.  Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Bing-Chang Chen; Huey-Mei Chang; Ming-Jen Hsu; Chwen-Ming Shih; Yi-Hua Chiu; Wen-Ta Chiu; Chien-Huang Lin
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

9.  mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment.

Authors:  Cosima Rhein; Iulia Zoicas; Lena M Marx; Stefanie Zeitler; Tobias Hepp; Claudia von Zimmermann; Christiane Mühle; Tanja Richter-Schmidinger; Bernd Lenz; Yesim Erim; Martin Reichel; Erich Gulbins; Johannes Kornhuber
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.

Authors:  Charles J Shoemaker; Kathryn L Schornberg; Sue E Delos; Corinne Scully; Hassan Pajouhesh; Gene G Olinger; Lisa M Johansen; Judith M White
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.